Table 3.
Multivariate COX regression analysis: Patient survival was analysed by multivariate COX regression analysis
| |
|
95% CI |
|
||
|---|---|---|---|---|---|
| Covariate | Coefficient (bi) | [HR Exp(bi)] | Lower | Upper | P-value |
|
FIGO stage |
|
|
|
|
<0.001 |
| I |
(0.000) |
(1.00) |
|
|
|
| II |
−3.064 |
.047 |
.011 |
.192 |
<0.001 |
| III |
−3.025 |
.049 |
.010 |
.233 |
<0.001 |
| IV |
−1.810 |
.164 |
.040 |
.669 |
.012 |
|
WHO grade |
|
|
|
|
.023 |
| 1 |
(0.000) |
(1.00) |
|
|
|
| 2 |
−.820 |
.440 |
.246 |
.790 |
.006 |
| 3 |
−.561 |
.571 |
.325 |
1.002 |
.051 |
|
Histology |
|
|
|
|
0.068 |
| Endometrioid |
(0.000) |
(1.00) |
|
|
|
| Serous |
−.297 |
.743 |
.233 |
2.372 |
.616 |
| Clear cell |
−.069 |
.934 |
.260 |
3.349 |
.916 |
| Mucinous |
−1.423 |
.241 |
.024 |
2.403 |
.225 |
| Squamous cell |
.074 |
1.077 |
.260 |
4.470 |
.918 |
| Mixed cell |
3.167 |
23.742 |
2.245 |
251.079 |
.008 |
| Undifferentiated |
−.163 |
.850 |
.255 |
2.828 |
.790 |
|
Lymph node metastasis |
−.732 |
.481 |
.209 |
1.109 |
.086 |
|
Age (≤50 y vs. >50 y) |
1.939 |
6.953 |
.909 |
53.204 |
.062 |
|
Diabetes |
.451 |
1.570 |
.880 |
2.800 |
.127 |
|
Obesity |
−.065 |
.937 |
.600 |
1.462 |
.774 |
|
Hypertension |
.454 |
1.575 |
1.043 |
2.380 |
.031 |
|
Lymphangiosis |
.216 |
1.241 |
.631 |
2.443 |
.532 |
|
Hemangiosis |
.681 |
1.975 |
.476 |
8.187 |
.348 |
|
ER alpha |
−.031 |
.970 |
.652 |
1.442 |
.880 |
|
PRA |
−.156 |
.855 |
.572 |
1.279 |
.446 |
|
GdA |
.840 |
2.317 |
1.362 |
3.943 |
.002 |
| Gd | −.298 | .743 | .456 | 1.209 | .232 |
Significant results are shown in bold.